These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22950625)

  • 21. Clinical role of thymidine phosphorylase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine.
    Tokunaga Y; Takahashi K; Saito T
    Hepatogastroenterology; 2005; 52(66):1715-21. PubMed ID: 16334763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extranodal metastasis predicts poor survival in advanced colorectal cancer.
    Tsutsumi S; Watanabe R; Tabe Y; Fujii T; Morita H; Kigure W; Kato T; Yamauchi H; Sakai M; Asao T; Kuwano H
    Hepatogastroenterology; 2012; 59(114):372-4. PubMed ID: 22353501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of high-risk stage II and stage III colorectal cancer by analysis of MMP-21 expression.
    Wu T; Li Y; Liu X; Lu J; He X; Wang Q; Li J; Du X
    J Surg Oncol; 2011 Dec; 104(7):787-91. PubMed ID: 21656525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinicopathological significance of the gene expression of matrix metalloproteinases and reversion-inducing cysteine-rich protein with Kazal motifs in patients with colorectal cancer: MMP-2 gene expression is a useful predictor of liver metastasis from colorectal cancer.
    Oshima T; Kunisaki C; Yoshihara K; Yamada R; Yamamoto N; Sato T; Makino H; Yamagishi S; Nagano Y; Fujii S; Shiozawa M; Akaike M; Wada N; Rino Y; Masuda M; Tanaka K; Imada T
    Oncol Rep; 2008 May; 19(5):1285-91. PubMed ID: 18425389
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of RGS2 expression and prognostic significance in stage II and III colorectal cancer.
    Jiang Z; Wang Z; Xu Y; Wang B; Huang W; Cai S
    Biosci Rep; 2010 Dec; 30(6):383-90. PubMed ID: 20001967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Expression and Significance of CXCR5 and MMP-13 in Colorectal Cancer.
    Yan Q; Yuan Y; Yankui L; Jingjie F; Linfang J; Yong P; Dong H; Xiaowei Q
    Cell Biochem Biophys; 2015 Sep; 73(1):253-9. PubMed ID: 25726157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
    Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
    Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of carcinoembryonic antigen and vascular endothelial growth factor tumor tissue content in colorectal cancer.
    Ferroni P; Palmirotta R; Spila A; Martini F; Formica V; Portarena I; Del Monte G; Buonomo O; Roselli M; Guadagni F
    Oncology; 2006; 71(3-4):176-84. PubMed ID: 17652942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
    Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
    Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
    Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
    Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma.
    Asano T; Tada M; Cheng S; Takemoto N; Kuramae T; Abe M; Takahashi O; Miyamoto M; Hamada J; Moriuchi T; Kondo S
    J Surg Res; 2008 May; 146(1):32-42. PubMed ID: 17543340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of MMP-9 and WAVE3 in colorectal cancer and its relationship to clinicopathological features.
    Zhang Y; Guan XY; Dong B; Zhao M; Wu JH; Tian XY; Hao CY
    J Cancer Res Clin Oncol; 2012 Dec; 138(12):2035-44. PubMed ID: 22806308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation of MT1-MMP gene expression to outcomes in colorectal cancer.
    Kanazawa A; Oshima T; Yoshihara K; Tamura S; Yamada T; Inagaki D; Sato T; Yamamoto N; Shiozawa M; Morinaga S; Akaike M; Kunisaki C; Tanaka K; Masuda M; Imada T
    J Surg Oncol; 2010 Nov; 102(6):571-5. PubMed ID: 20721961
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High Rab27A expression indicates favorable prognosis in CRC.
    Shi C; Yang X; Ni Y; Hou N; Xu L; Zhan F; Zhu H; Xiong L; Chen P
    Diagn Pathol; 2015 Jun; 10():68. PubMed ID: 26070933
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A multivariate analysis of adhesion molecules expression in assessment of colorectal cancer.
    Ngan CY; Yamamoto H; Seshimo I; Ezumi K; Terayama M; Hemmi H; Takemasa I; Ikeda M; Sekimoto M; Monden M
    J Surg Oncol; 2007 Jun; 95(8):652-62. PubMed ID: 17443723
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunohistochemical dihydropyrimidine dehydrogenase expression is a good prognostic indicator for patients with Dukes' C colorectal cancer.
    Oi K; Makino M; Ozaki M; Takemoto H; Yamane N; Nakamura S; Ikeguchi M; Kaibara N
    Anticancer Res; 2004; 24(1):273-9. PubMed ID: 15015608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of thymidylate synthase expression in lymph node metastases of colorectal cancer can improve the prognostic information.
    Ohrling K; Edler D; Hallström M; Ragnhammar P; Blomgren H
    J Clin Oncol; 2005 Aug; 23(24):5628-34. PubMed ID: 16009948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunohistochemical analysis of colorectal cancer with gastric phenotype: claudin-18 is associated with poor prognosis.
    Matsuda M; Sentani K; Noguchi T; Hinoi T; Okajima M; Matsusaki K; Sakamoto N; Anami K; Naito Y; Oue N; Yasui W
    Pathol Int; 2010 Oct; 60(10):673-80. PubMed ID: 20846265
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
    Hu WG; Li JW; Feng B; Beveridge M; Yue F; Lu AG; Ma JJ; Wang ML; Guo Y; Jin XL; Zheng MH
    Eur Surg Res; 2007; 39(4):229-38. PubMed ID: 17446709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
    Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
    J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.